• Online Features  This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (8)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Neurology  • Multiple Sclerosis/ Demyelinating Disease  • Radiologic Imaging  • Magnetic Resonance Imaging  • Immunologic Disorders  • Alert me on articles by topic  Social Bookmarking   What's this?

Paul S. Giacomini, MD, FRCPC; Ives R. Levesque, MSc; Luciana Ribeiro, MD; Sridar Narayanan, PhD; Simon J. Francis, MSc; G. Bruce Pike, PhD; Douglas L. Arnold, MD, FRCPC

Arch Neurol. 2009;66(3):375-381.

Objective  To validate the use of the magnetization transfer ratio (MTR) as a practical imaging marker of demyelination and remyelination in acute multiple sclerosis lesions.

Design  Case study.

Setting  University hospital multiple sclerosis clinic.

Patients  Six patients with relapsing-remitting multiple sclerosis and acute gadolinium-enhancing lesions were studied serially using a quantitative magnetization transfer examination.

Main Outcome Measures  Changes in the water content and macromolecular content, a marker of myelin content that, unlike MTR, is not affected by changes in water content (edema) associated with acute inflammation, and changes in MTR of lesions.

Results  Both the macromolecular content and MTR were lower than normal in acute lesions and recovered over several months. The decrease in macromolecular content relative to contralateral normal-appearing white matter was greater than the decrease in MTR (0.46 vs 0.75 at the time of gadolinium enhancement), likely because edema in the acute lesion increased the T1 relaxation time of water and attenuated the decrease in MTR. Nevertheless, there was still a strong correlation between changes in the relative MTR and macromolecular content (R² = 0.70; P < .001).

Conclusion  Our data support the use of MTR as a practical marker of demyelination and remyelination, even in acute lesions where decreases in MTR are attenuated because of the effects of edema.

Author Affiliations: McConnell Brain Imaging Centre, Montreal Neurological Institute, Montreal, Quebec (Drs Giacomini, Levesque, Ribeiro, Narayanan, Francis, Pike, and Arnold) and McMaster University Medical Centre, Hamilton, Ontario (Dr Ribeiro), Canada.

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

This Month in Archives of Neurology
Arch Neurol. 2009;66(3):298-299.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

VCAM-1-targeted magnetic resonance imaging reveals subclinical disease in a mouse model of multiple sclerosis
Serres et al.
FASEB J. 2011;25:4415-4422.
ABSTRACT | FULL TEXT  

Magnetization Transfer Imaging Provides No Evidence of Demyelination in Methotrexate-Induced Encephalopathy
Miese et al.
Am. J. Neuroradiol. 2011;32:E110-E112.
ABSTRACT | FULL TEXT